Disorders of Eccrine and Apocrine Glands


Eccrine and apocrine glands represent the two major types of sweat glands (see Fig. 91.1 ).

Eccrine Glands

  • Functional from birth and activated by thermal stimuli via the hypothalamic sweat center; while their major function is thermoregulation by evaporative heat loss, they are also activated by emotional stimuli.

  • Innervated by sympathetic fibers that have acetylcholine as their major neurotransmitter.

  • Generalized distribution, with greatest concentration on the palms and soles.

  • The eccrine duct opens directly onto the skin surface, and the excretory product is a clear hypotonic fluid that is mostly water but also contains NaCl.

Apocrine Glands

  • Unclear function in humans; functional development requires androgens.

  • More limited distribution – primarily axillae, nipples/areolae, and umbilical and anogenital regions; modified apocrine glands are found in the external auditory canals and eyelid margins.

  • The apocrine duct drains into the superficial portion of the hair follicle (see Fig. 91.1 ).

  • “Decapitation” of apocrine gland cells produces an odorless and viscous fluid; however, its degradation by flora on the skin surface can lead to an odor.

Hyperhidrosis

  • Excessive production of eccrine sweat is usually due to primary cortical (emotional) hyperhidrosis and the favored sites are the axillae or palms and soles ( Fig. 32.1 ) > the face ( Fig. 32.2 ); involvement is bilateral and symmetric ( Fig. 32.3 ).

    Fig. 32.1, Volar hyperhidrosis (primary cortical).

    Fig. 32.2, Primary cortical (emotional) hyperhidrosis involving the face.

    Fig. 32.3, Palmar hyperhidrosis as assessed by the semiquantitative starch paper–iodine technique.

  • Secondary cortical hyperhidrosis is associated with genodermatoses, including palmoplantar keratodermas and epidermolysis bullosa simplex; associated odor reflects maceration and degradation of keratin by bacteria.

  • Secondary hypothalamic (thermoregulatory) hyperhidrosis can be due to a number of systemic diseases, from infections to neoplasms ( Table 32.1 ).

    Table 32.1
    Causes of secondary hypothalamic hyperhidrosis.
    CVA, cerebrovascular accident; MAOI, monoamine oxidase inhibitor; RSD, reflex sympathetic dystrophy, also referred to as complex regional pain syndrome. Linezolid is an MAOI.
    • Infections , e.g. acute febrile bacterial and viral infections (defervescence), malaria

    • Neoplasms , e.g. lymphoma (B symptom), pheochromocytoma

    • Endocrinologic disorders , e.g. hypoestrogenemia of menopause, hyperthyroidism

    • Vasomotor disorders , e.g. cold injury, Raynaud phenomenon, RSD

    • Neurologic diseases , e.g. CNS tumors, CVAs (contralateral)

    • Drugs and toxins , e.g. opioid withdrawal, alcohol withdrawal, combination of drugs that result in the serotonin syndrome (MAOI plus tricyclic or SSRI antidepressant)

    • Miscellaneous , e.g. compensatory in the setting of a sympathectomy, extensive miliaria or diabetes mellitus

  • Secondary medullary (gustatory) hyperhidrosis can be physiologic as exemplified by the facial sweating that occurs with spicy foods, or pathologic as occurs in Frey syndrome ( Fig. 32.4 ); in the former, taste receptors send afferent impulses, whereas in the latter, disrupted nerves for sweat aberrantly connect with nerves for salivation.

    Fig. 32.4, Gustatory sweating in the auriculotemporal (Frey) syndrome, as a consequence of parotid surgery.

  • Injuries or diseases affecting the spinal cord can result in segmental hyperhidrosis.

  • In addition to embarrassment, hyperhidrosis can lead to overhydration of the skin and a higher risk of bacterial and fungal infections.

  • Sweating only during waking hours points to primary cortical (emotional) hyperhidrosis; after consideration of possible underlying etiologies, topical antiperspirants containing aluminum chloride (e.g. Certain Dri®) or aluminum chloride hexahydrate (e.g. Xerac™ AC [6.25%], Drysol® [20%]) can be applied at bedtime, and if necessary, initially preceded by oral glycopyrrolate or oxybutynin. A glycopyrronium-containing cloth can also be applied daily.

  • Injection of botulinum toxin type A every ∼6 months is very effective for primary cortical (emotional) hyperhidrosis ( Fig. 32.5 ); tap water iontophoresis is less effective.

    Fig. 32.5, Delineation of area for injections of botulinum toxin A for axillary hyperhidrosis (starch–iodine technique).

Hypohidrosis (and Anhidrosis)

  • There are multiple etiologies of hypohidrosis and anhidrosis including the following:

    • A side effect of medications with anticholinergic properties (e.g. atropine, tricyclic antidepressants, glycopyrrolate)

    • Manifestation of inherited disorders, in particular ectodermal dysplasias (see Ch. 52 ), as well as acquired disorders such as Sjögren syndrome

    • Neurologic disorders, from tumors or infarcts of the hypothalamus, pons or medulla to peripheral neuropathies

    • Rarely, and primarily in Asians, due to acquired idiopathic generalized anhidrosis

  • Increased risk of developing hyperthermia.

  • Evaluation includes colorimetric testing (see Fig. 32.5 ) and biopsy of affected skin.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here